Post-earnings recap
Reported
Wed, Nov 12, 2025
EPS actual
$-0.78
EPS est.
$-1.05
EPS surprise
+25.71%
1-day move
+7.56%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Celcuity's earnings report showed a better-than-expected EPS, which likely contributed to the stock's 7.56% increase in response. Investors may have reacted positively to the management's comments on their clinical trial progress, indicating potential future growth. However, the lack of revenue data and guidance leaves some uncertainty about the company's immediate financial outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.78 | N/A | +25.71% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism regarding future developments. They emphasized ongoing efforts to advance their pipeline.
Management highlighted the progress in their clinical trials.
They expressed confidence in their long-term strategy despite current challenges.